Montelukast is an orally dosed drug (available as a film-coated tablet, chewable tablet, or oral granules) that is FDA-approved for treating the following conditions.

- **Asthma:**Monteleulast is indicated for asthma prophylaxis and chronic treatment in adults and pediatric patients 12 months of age and older.

- **Exercise-Induced Bronchoconstriction (EIB):**Montelukast is indicated to prevent exercise-induced bronchoconstriction (EIB) in patients six years of age and older.

- **Seasonal Allergic Rhinitis:**Montelukast is indicated to relieve symptoms of seasonal allergic rhinitis in patients two years of age and more; and perennial allergic rhinitis in patients six months of age and older. Because the benefits of montelukast may not outweigh the risk of neuropsychiatric adverse reactions in patients with allergic rhinitis, only used for patients who have an intolerance or an inadequate response to alternative therapies.